These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


138 related items for PubMed ID: 3923594

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Mass vaccination against rubella in Iceland after cost-benefit analysis].
    Olafsson O.
    Nord Med; 1979 Sep; 94(8-9):203. PubMed ID: 113774
    [No Abstract] [Full Text] [Related]

  • 4. Benefit-cost analysis of rubella vaccination policy.
    Schoenbaum SC, Hyde JN Jr Bartoshesky L, Crampton K.
    N Engl J Med; 1976 Feb 05; 294(6):306-10. PubMed ID: 813141
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study.
    Bae GR, Choe YJ, Go UY, Kim YI, Lee JK.
    Vaccine; 2013 May 31; 31(24):2661-6. PubMed ID: 23602654
    [Abstract] [Full Text] [Related]

  • 8. Theoretical aspects of rubella vaccination strategies.
    Knox EG.
    Rev Infect Dis; 1985 May 31; 7 Suppl 1():S194-7. PubMed ID: 4001728
    [Abstract] [Full Text] [Related]

  • 9. [Strategies for the prevention of congenital rubella].
    Buekens P.
    Rev Epidemiol Sante Publique; 1983 May 31; 31(3):283-8. PubMed ID: 6658102
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prevention of congenital rubella and congenital varicella in Europe.
    Pandolfi E, Chiaradia G, Moncada M, Rava L, Tozzi AE.
    Euro Surveill; 2009 Mar 05; 14(9):16-20. PubMed ID: 19317971
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Targeting rubella for elimination.
    Taneja DK, Sharma P.
    Indian J Public Health; 2012 Mar 05; 56(4):269-72. PubMed ID: 23354136
    [Abstract] [Full Text] [Related]

  • 16. Seroprevalence of rubella among women of childbearing age in Taiwan after nationwide vaccination.
    Su SB, Guo HR.
    Am J Trop Med Hyg; 2002 Nov 05; 67(5):549-53. PubMed ID: 12479561
    [Abstract] [Full Text] [Related]

  • 17. Quantitative investigations of different vaccination policies for the control of congenital rubella syndrome (CRS) in the United Kingdom.
    Anderson RM, Grenfell BT.
    J Hyg (Lond); 1986 Apr 05; 96(2):305-33. PubMed ID: 3701044
    [Abstract] [Full Text] [Related]

  • 18. Epidemiology of rubella and congenital rubella infection in Israel, a country with a selective immunization program.
    Swartz TA, Hornstein L, Epstein I.
    Rev Infect Dis; 1985 Apr 05; 7 Suppl 1():S42-6. PubMed ID: 4001732
    [Abstract] [Full Text] [Related]

  • 19. Congenital rubella surveillance following epidemic rubella in a partially vaccinated community.
    Rachelefsky GS, Herrmann KL.
    J Pediatr; 1974 Apr 05; 84(4):474-8. PubMed ID: 4834242
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.